Neal Dingmann, Analyst—Question
Morning, both teams. Nice deal. David, my first question is maybe just around what I call sort of the deal sequence specifically. I don’t know, any color you might be able to add on how this deal came to be. Certainly, what’s attractive from our side, I’m just wondering. Well, I know you and Brandi and the team are always looking for accretive deals. I mean, was this something that you’d shot for a while? I’m just wondering maybe how competitive the process or just anything else you could add on how this thing came to be.
David C. Rockecharlie, Chief Executive Officer and Member of the Board of Directors—Answer
Yeah. No, great question. And look, I definitely can’t speak to a broader process other than kind of our engagement. But as hopefully all of our shareholders appreciate, we’ve been focused in the Eagle Ford for a long time. This is a great company that Sean and the team have built. So we’ve obviously known each other and been able to observe their performance. And so, again, as Sean said in the opening, this did come together relatively recently around the, obviously, announcement here. But long story short, we think this is a perfect fit and the pro forma company is just really going to be outstanding going forward.
Neal Dingmann, Analyst—Question
In that pro forma you have that you spoke of, David, is that the four to five that you see that running well into next year, those four to five rigs, sort of as you’ve been running – as a combo has been running?
David C. Rockecharlie, Chief Executive Officer and Member of the Board of Directors—Answer
Yeah. In the short-term, obviously, we’re not going to change any or provide any combined guidance. And as you know, we can’t really do anything separately until the closing. So I think what you see is what you get for now. But our strong belief and conviction here is that the two companies together are going to create a lot more than separately, and I think we were doing really well separately.
Neal Dingmann, Analyst—Question
Got it. Got it. And then just, secondly, maybe for Sean, I’m just wondering obviously besides the Kimmeridge, I’m just wondering, Sean, if you’ve all been sort of actively shopping or anything you might be able to say on the sell side? I’m just wondering maybe why you believe if now is the right time and how does – I know there was a poison pill out there. Does this remove that as well?
Sean C. Woolverton, Chief Executive Officer & Director—Answer
Hey, good morning, Neal. Appreciate the question. I think, as David mentioned, both companies have been very actively involved in the basin. Between the two of us, we’ve been that active a consolidator. And so we’ve got to know each other over the last couple of years. And as David mentioned more recently, our engagements kind of ticked up on the strength of closing to our – their acquisitions last year and ours as well. So we’re really excited on this company – combination. As I’ve always said, SilverBow is the biggest cheerleader of consolidation in the basin. And we said, hey, we’d do it from a buy-side and the sell-side.
So, our Board, management team has been very focused on creating value for all of our shareholders and has long indicated an openness to a transaction. We really evaluated a wide range of activities and engaged with multiple parties for some time, including Kimmeridge over the last couple of years. There’s a long list of information out there on our engagement with them over the past couple of years. So we’re just really excited about the deal. This transaction offers a premium for our shareholders upfront, but more importantly, gives them the opportunity to participate in what I think is going to be a phenomenal company go-forward.
Neal Dingmann, Analyst—Question
And does this change with the – is the poison pill still out there? What is it – what does it do on that side?
Sean C. Woolverton, Chief Executive Officer & Director—Answer
From the pill, what you’re going to see is that it’s going to be extended through the closing of the transation. And that was agreed mutually with Crescent as part of the merger agreement.
Neal Dingmann, Analyst – Question
Got it. Okay. Thank you, guys. So, congrats on both sides.
David C. Rockecharlie, Chief Executive Officer and Member of the Board of Directors – Answer
Thank you.
Operator
Our next question comes from Leo Mariani from ROTH MKM. Please proceed.
Leo Mariani, Analyst – Question
Hi, guys. I was hoping you could elaborate a bit more here on the synergies. If I’m reading the slides right, it sounds like you guys are expecting to kind of refinance the debt later this year. And there’s a mention of G&A synergies and then, obviously, the operational synergies. Can you maybe just provide us a little bit more clarity in terms of when you plan to kind of tackle each of these items from G&A to kind of some of the upside from a timing perspective? And then, can you just also elaborate on the G&A side in terms of what you kind of maybe planning to keep here in terms of SilverBow employees?
4